Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1996 Feb;164(2):143–155.

Biology and treatment of adult acute lymphoblastic leukemia.

L Levitt 1, R Lin 1
PMCID: PMC1303386  PMID: 8775728

Abstract

The molecular analysis of acute lymphoblastic leukemia (ALL) has provided exciting insights into the pathogenesis of this disease. This disease is heterogenous and can be subtyped based on chromosomal, immunophenotypic, and structural criteria. The varying prognostic implications of different ALL subtypes markedly influence the treatment decisions in adults. Many patients with T-cell ALL can be cured with chemotherapy alone. In contrast, patients with early B-lineage ALL with certain chromosomal abnormalities, especially the Philadelphia chromosome, do not have durable responses to chemotherapy and should receive a bone marrow transplantation if an HLA-matched donor is available. Recent reports have shown improved results for adults with B-cell ALL (Burkitt's) after intensive alternating cycles of chemotherapy containing high doses of methotrexate and cyclophosphamide. Future clinical and laboratory investigation should lead to the development of novel and possibly more effective treatments specifically tailored for different subsets of ALL.

Full text

PDF
143

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe R., Sandberg A. A. Significance of abnormalities involving chromosomal segment 11q22-25 in acute leukemia. Cancer Genet Cytogenet. 1984 Oct;13(2):121–127. doi: 10.1016/0165-4608(84)90053-0. [DOI] [PubMed] [Google Scholar]
  2. Adams J. M., Gerondakis S., Webb E., Corcoran L. M., Cory S. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc Natl Acad Sci U S A. 1983 Apr;80(7):1982–1986. doi: 10.1073/pnas.80.7.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Adams J. M., Harris A. W., Pinkert C. A., Corcoran L. M., Alexander W. S., Cory S., Palmiter R. D., Brinster R. L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 1985 Dec 12;318(6046):533–538. doi: 10.1038/318533a0. [DOI] [PubMed] [Google Scholar]
  4. Arcese W., Amadori S., Meloni G., Giona F., Vegna M. L., Testi A. M., Annino L., Carotenuto M., Resegotti L., Madon E. Allogeneic or autologous bone marrow transplantation for intensification of salvage therapy in patients with high-risk advanced acute lymphoblastic leukemia. The AIEOP/GIMEMA Groups. Semin Hematol. 1991 Jul;28(3 Suppl 4):116–121. [PubMed] [Google Scholar]
  5. Arlin Z. A., Feldman E., Kempin S., Ahmed T., Mittelman A., Savona S., Ascensao J., Baskind P., Sullivan P., Fuhr H. G. Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults. Blood. 1988 Aug;72(2):433–435. [PubMed] [Google Scholar]
  6. Auber M. L., Horwitz L. J., Blaauw A., Khorana S., Tucker S., Woods T., Warmuth M., Dicke K. A., McCredie K. B., Spitzer G. Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia. Blood. 1988 Jan;71(1):166–172. [PubMed] [Google Scholar]
  7. Bachhuber R., Fitchen J. H., Harty-Golder B. Rash and eosinophilia in a 23-year-old man. West J Med. 1982 Sep;137(3):221–227. [PMC free article] [PubMed] [Google Scholar]
  8. Barnett M. J., Greaves M. F., Amess J. A., Gregory W. M., Rohatiner A. Z., Dhaliwal H. S., Slevin M. L., Biruls R., Malpas J. S., Lister T. A. Treatment of acute lymphoblastic leukaemia in adults. Br J Haematol. 1986 Nov;64(3):455–468. doi: 10.1111/j.1365-2141.1986.tb02201.x. [DOI] [PubMed] [Google Scholar]
  9. Barrett A. J., Horowitz M. M., Ash R. C., Atkinson K., Gale R. P., Goldman J. M., Henslee-Downey P. J., Herzig R. H., Speck B., Zwaan F. E. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 1992 Jun 1;79(11):3067–3070. [PubMed] [Google Scholar]
  10. Beatty P. G., Hansen J. A., Longton G. M., Thomas E. D., Sanders J. E., Martin P. J., Bearman S. I., Anasetti C., Petersdorf E. W., Mickelson E. M. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation. 1991 Feb;51(2):443–447. doi: 10.1097/00007890-199102000-00034. [DOI] [PubMed] [Google Scholar]
  11. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 Aug;33(4):451–458. doi: 10.1111/j.1365-2141.1976.tb03563.x. [DOI] [PubMed] [Google Scholar]
  12. Biggs J. C., Horowitz M. M., Gale R. P., Ash R. C., Atkinson K., Helbig W., Jacobsen N., Phillips G. L., Rimm A. A., Ringdén O. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood. 1992 Aug 15;80(4):1090–1093. [PubMed] [Google Scholar]
  13. Blaise D., Gaspard M. H., Stoppa A. M., Michel G., Gastaut J. A., Lepeu G., Tubiana N., Blanc A. P., Rossi J. F., Novakovitch G. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission. Bone Marrow Transplant. 1990 Jan;5(1):7–12. [PubMed] [Google Scholar]
  14. Bleyer W. A., Poplack D. G. Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: prolonged remission with the Ommaya reservoir. Med Pediatr Oncol. 1979;6(3):207–213. doi: 10.1002/mpo.2950060304. [DOI] [PubMed] [Google Scholar]
  15. Bleyer W. A., Poplack D. G. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol. 1985 Jun;12(2):131–148. [PubMed] [Google Scholar]
  16. Bloomfield C. D., Secker-Walker L. M., Goldman A. I., Van Den Berghe H., de la Chapelle A., Ruutu T., Alimena G., Garson O. M., Golomb H. M., Rowley J. D. Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1989 Jul 15;40(2):171–185. doi: 10.1016/0165-4608(89)90023-x. [DOI] [PubMed] [Google Scholar]
  17. Blume K. G., Schmidt G. M., Chao N. J., Forman S. J. Bone marrow transplantation from histocompatible sibling donors for patients with acute lymphoblastic leukemia. Haematol Blood Transfus. 1990;33:636–637. doi: 10.1007/978-3-642-74643-7_115. [DOI] [PubMed] [Google Scholar]
  18. Bortin M. M., Horowitz M. M., Rowlings P. A., Rimm A. A., Sobocinski K. A., Zhang M. J., Gale R. P. 1993 progress report from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant Registry. Bone Marrow Transplant. 1993 Aug;12(2):97–104. [PubMed] [Google Scholar]
  19. Bouffet E., Frappaz D., Pinkerton R., Favrot M., Philip T. Burkitt's lymphoma: a model for clinical oncology. Eur J Cancer. 1991;27(4):504–509. doi: 10.1016/0277-5379(91)90397-v. [DOI] [PubMed] [Google Scholar]
  20. Brisco M. J., Condon J., Hughes E., Neoh S. H., Sykes P. J., Seshadri R., Toogood I., Waters K., Tauro G., Ekert H. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet. 1994 Jan 22;343(8891):196–200. doi: 10.1016/s0140-6736(94)90988-1. [DOI] [PubMed] [Google Scholar]
  21. Busca A., Anasetti C., Anderson G., Appelbaum F. R., Buckner C. D., Doney K., Martin P. J., Petersdorf E., Sanders J. E., Hansen J. A. Unrelated donor or autologous marrow transplantation for treatment of acute leukemia. Blood. 1994 May 15;83(10):3077–3084. [PubMed] [Google Scholar]
  22. Carella A. M., Podestà M., Frassoni F., Pungolino E., Pollicardo N., Raffo M. R., Ferrero R., Benvenuto F., Figari O., Giordano D. Selective overshoot of Ph-negative blood hemopoietic cells after intensive idarubicin-containing regimen and their repopulating capacity after reinfusion. Stem Cells. 1993 Oct;11 (Suppl 3):67–72. doi: 10.1002/stem.5530110917. [DOI] [PubMed] [Google Scholar]
  23. Carella A. M., Pollicardo N., Pungolino E., Raffo M. R., Podesta M., Ferrero R., Pierluigi D., Nati S., Naibo K., Congiu A. Mobilization of cytogenetically 'normal' blood progenitors cells by intensive conventional chemotherapy for chronic myeloid and acute lymphoblastic leukemia. Leuk Lymphoma. 1993 Apr;9(6):477–483. doi: 10.3109/10428199309145754. [DOI] [PubMed] [Google Scholar]
  24. Carroll A. J., Crist W. M., Parmley R. T., Roper M., Cooper M. D., Finley W. H. Pre-B cell leukemia associated with chromosome translocation 1;19. Blood. 1984 Mar;63(3):721–724. [PubMed] [Google Scholar]
  25. Chan-Lam D., Prentice A. G., Copplestone J. A., Weston M., Williams M., Hutton C. W. Avascular necrosis of bone following intensified steroid therapy for acute lymphoblastic leukaemia and high-grade malignant lymphoma. Br J Haematol. 1994 Jan;86(1):227–230. doi: 10.1111/j.1365-2141.1994.tb03287.x. [DOI] [PubMed] [Google Scholar]
  26. Chao N. J., Forman S. J., Schmidt G. M., Snyder D. S., Amylon M. D., Konrad P. N., Nademanee A. P., O'Donnell M. R., Parker P. M., Stein A. S. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Blood. 1991 Oct 15;78(8):1923–1927. [PubMed] [Google Scholar]
  27. Chao N. J., Schriber J. R., Grimes K., Long G. D., Negrin R. S., Raimondi C. M., Horning S. J., Brown S. L., Miller L., Blume K. G. Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood. 1993 Apr 15;81(8):2031–2035. [PubMed] [Google Scholar]
  28. Chen Q., Cheng J. T., Tasi L. H., Schneider N., Buchanan G., Carroll A., Crist W., Ozanne B., Siciliano M. J., Baer R. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J. 1990 Feb;9(2):415–424. doi: 10.1002/j.1460-2075.1990.tb08126.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Childs C. C., Hirsch-Ginsberg C., Walters R. S., Andersson B. S., Reuben J., Trujillo J. M., Cork A., Stass S. A., Freireich E. J., Zipf T. F. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics. Leukemia. 1989 Nov;3(11):777–783. [PubMed] [Google Scholar]
  30. Cohen L. F., Balow J. E., Magrath I. T., Poplack D. G., Ziegler J. L. Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med. 1980 Apr;68(4):486–491. doi: 10.1016/0002-9343(80)90286-7. [DOI] [PubMed] [Google Scholar]
  31. Croce C. M., Isobe M., Palumbo A., Puck J., Ming J., Tweardy D., Erikson J., Davis M., Rovera G. Gene for alpha-chain of human T-cell receptor: location on chromosome 14 region involved in T-cell neoplasms. Science. 1985 Mar 1;227(4690):1044–1047. doi: 10.1126/science.3919442. [DOI] [PubMed] [Google Scholar]
  32. Daley G. Q., Van Etten R. A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science. 1990 Feb 16;247(4944):824–830. doi: 10.1126/science.2406902. [DOI] [PubMed] [Google Scholar]
  33. Dedera D. A., Waller E. K., LeBrun D. P., Sen-Majumdar A., Stevens M. E., Barsh G. S., Cleary M. L. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell. 1993 Sep 10;74(5):833–843. doi: 10.1016/0092-8674(93)90463-z. [DOI] [PubMed] [Google Scholar]
  34. Denny C. T., Yoshikai Y., Mak T. W., Smith S. D., Hollis G. F., Kirsch I. R. A chromosome 14 inversion in a T-cell lymphoma is caused by site-specific recombination between immunoglobulin and T-cell receptor loci. Nature. 1986 Apr 10;320(6062):549–551. doi: 10.1038/320549a0. [DOI] [PubMed] [Google Scholar]
  35. Diaz M. O., Le Beau M. M., Pitha P., Rowley J. D. Interferon and c-ets-1 genes in the translocation (9;11)(p22;q23) in human acute monocytic leukemia. Science. 1986 Jan 17;231(4735):265–267. doi: 10.1126/science.3455787. [DOI] [PubMed] [Google Scholar]
  36. Doney K., Buckner C. D., Fisher L., Petersen F. B., Sanders J., Appelbaum F. R., Anasetti C., Badger C., Bensinger W., Deeg H. J. Autologous bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant. 1993 Oct;12(4):315–321. [PubMed] [Google Scholar]
  37. Drexler H. G., Thiel E., Ludwig W. D. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia. 1991 Aug;5(8):637–645. [PubMed] [Google Scholar]
  38. Ellison R. R., Mick R., Cuttner J., Schiffer C. A., Silver R. T., Henderson E. S., Woliver T., Royston I., Davey F. R., Glicksman A. S. The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B. J Clin Oncol. 1991 Nov;9(11):2002–2015. doi: 10.1200/JCO.1991.9.11.2002. [DOI] [PubMed] [Google Scholar]
  39. Fenaux P., Lai J. L., Miaux O., Zandecki M., Jouet J. P., Bauters F. Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases. Br J Haematol. 1989 Mar;71(3):371–376. doi: 10.1111/j.1365-2141.1989.tb04294.x. [DOI] [PubMed] [Google Scholar]
  40. Fiere D., Extra J. M., David B., Witz F., Vernand J. P., Gastaut J. A., Dauriac C., Pris J., Marty M. Treatment of 218 adult acute lymphoblastic leukemias. Semin Oncol. 1987 Jun;14(2 Suppl 1):64–66. [PubMed] [Google Scholar]
  41. Fière D., Lepage E., Sebban C., Boucheix C., Gisselbrecht C., Vernant J. P., Varet B., Broustet A., Cahn J. Y., Rigal-Huguet F. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia. J Clin Oncol. 1993 Oct;11(10):1990–2001. doi: 10.1200/JCO.1993.11.10.1990. [DOI] [PubMed] [Google Scholar]
  42. Foa R., Migone N., Saitta M., Fierro M. T., Giubellino M. C., Lusso P., Cordero di Montezemolo L., Miniero R., Lauria F. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia. J Clin Invest. 1984 Nov;74(5):1756–1763. doi: 10.1172/JCI111594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Freund M., De Boben M., Diedrich H., Ganser A., Heil G., Heyll A., Henke M., Hiddemann W., Knauf U., Koch P. Treatment of relapsed acute lymphocytic leukemia in adults. Haematol Blood Transfus. 1990;33:432–436. doi: 10.1007/978-3-642-74643-7_80. [DOI] [PubMed] [Google Scholar]
  44. Gale R. P., Ben Bassat I. Hybrid acute leukaemia. Br J Haematol. 1987 Mar;65(3):261–264. doi: 10.1111/j.1365-2141.1987.tb06851.x. [DOI] [PubMed] [Google Scholar]
  45. Gaynor J., Chapman D., Little C., McKenzie S., Miller W., Andreeff M., Arlin Z., Berman E., Kempin S., Gee T. A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969. J Clin Oncol. 1988 Jun;6(6):1014–1030. doi: 10.1200/JCO.1988.6.6.1014. [DOI] [PubMed] [Google Scholar]
  46. Gill P. S., Meyer P. R., Pavlova Z., Levine A. M. B cell acute lymphocytic leukemia in adults. Clinical, morphologic, and immunologic findings. J Clin Oncol. 1986 May;4(5):737–743. doi: 10.1200/JCO.1986.4.5.737. [DOI] [PubMed] [Google Scholar]
  47. Gilmore M. J., Hamon M. D., Prentice H. G., Katz F., Slaper-Cortenbach I. C., Hunter A. E., Gandhi L., Brenner M. K., Hoffbrand A. V., Mehta A. B. Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission. Bone Marrow Transplant. 1991 Jul;8(1):19–26. [PubMed] [Google Scholar]
  48. Gingrich R. D., Burns C. P., Armitage J. O., Aunan S. B., Edwards R. W., Dick F. R., Maguire L. C., Leimert J. T. Long-term relapse-free survival in adult acute lymphoblastic leukemia. Cancer Treat Rep. 1985 Feb;69(2):153–160. [PubMed] [Google Scholar]
  49. Gorin N. C., Aegerter P., Auvert B. Autologous bone marrow transplantation for acute leukemia in remission: an analysis of 1322 cases. Haematol Blood Transfus. 1990;33:660–666. doi: 10.1007/978-3-642-74643-7_120. [DOI] [PubMed] [Google Scholar]
  50. Gottlieb A. J., Weinberg V., Ellison R. R., Henderson E. S., Terebelo H., Rafla S., Cuttner J., Silver R. T., Carey R. W., Levy R. N. Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B. Blood. 1984 Jul;64(1):267–274. [PubMed] [Google Scholar]
  51. Guyotat D., Campos L., Shi Z. H., Charrin C., Treille D., Magaud J. P., Fiere D. Myeloid surface antigen expression in adult acute lymphoblastic leukemia. Leukemia. 1990 Sep;4(9):664–666. [PubMed] [Google Scholar]
  52. Hagemeijer A., van der Plas D. C. Clinical relevance of cytogenetics in acute leukemia. Haematol Blood Transfus. 1990;33:23–30. doi: 10.1007/978-3-642-74643-7_4. [DOI] [PubMed] [Google Scholar]
  53. Heisterkamp N., Jenster G., ten Hoeve J., Zovich D., Pattengale P. K., Groffen J. Acute leukaemia in bcr/abl transgenic mice. Nature. 1990 Mar 15;344(6263):251–253. doi: 10.1038/344251a0. [DOI] [PubMed] [Google Scholar]
  54. Henderson E. S., Scharlau C., Cooper M. R., Haurani F. I., Silver R. T., Brunner K., Carey R. W., Falkson G., Blom J., Nawabi I. V. Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: results of CALGB protocol 7113. Leuk Res. 1979;3(6):395–407. doi: 10.1016/0145-2126(79)90036-5. [DOI] [PubMed] [Google Scholar]
  55. Hess C. E., Zirkle J. W. Results of induction therapy with vincristine and prednisone alone in adult acute lymphoblastic leukemia: report of 43 patients and review of the literature. Am J Hematol. 1982 Aug;13(1):63–71. doi: 10.1002/ajh.2830130108. [DOI] [PubMed] [Google Scholar]
  56. Hirsch-Ginsberg C., Huh Y. O., Kagan J., Liang J. C., Stass S. A. Advances in the diagnosis of acute leukemia. Hematol Oncol Clin North Am. 1993 Feb;7(1):1–46. [PubMed] [Google Scholar]
  57. Hoelzer D., Thiel E., Löffler H., Büchner T., Ganser A., Heil G., Koch P., Freund M., Diedrich H., Rühl H. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood. 1988 Jan;71(1):123–131. [PubMed] [Google Scholar]
  58. Hoelzer D. Treatment of acute lymphoblastic leukemia. Semin Hematol. 1994 Jan;31(1):1–15. [PubMed] [Google Scholar]
  59. Horowitz M. M., Messerer D., Hoelzer D., Gale R. P., Neiss A., Atkinson K., Barrett A. J., Büchner T., Freund M., Heil G. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med. 1991 Jul 1;115(1):13–18. doi: 10.7326/0003-4819-115-1-13. [DOI] [PubMed] [Google Scholar]
  60. Hughes T. P., Morgan G. J., Martiat P., Goldman J. M. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood. 1991 Feb 15;77(4):874–878. [PubMed] [Google Scholar]
  61. Huret J. L., Brizard A., Slater R., Charrin C., Bertheas M. F., Guilhot F., Hählen K., Kroes W., van Leeuwen E., Schoot E. V. Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients--updated published cases and 16 new observations. Leukemia. 1993 Feb;7(2):152–160. [PubMed] [Google Scholar]
  62. Hussein K. K., Dahlberg S., Head D., Waddell C. C., Dabich L., Weick J. K., Morrison F., Saiki J. H., Metz E., Rivkin S. E. Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy. Blood. 1989 Jan;73(1):57–63. [PubMed] [Google Scholar]
  63. Jongeneel C. V., Quackenbush E. J., Ronco P., Verroust P., Carrel S., Letarte M. Common acute lymphoblastic leukemia antigen expressed on leukemia and melanoma cell lines has neutral endopeptidase activity. J Clin Invest. 1989 Feb;83(2):713–717. doi: 10.1172/JCI113936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Kagan J., Finger L. R., Letofsky J., Finan J., Nowell P. C., Croce C. M. Clustering of breakpoints on chromosome 10 in acute T-cell leukemias with the t(10;14) chromosome translocation. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4161–4165. doi: 10.1073/pnas.86.11.4161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Kamps M. P., Murre C., Sun X. H., Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell. 1990 Feb 23;60(4):547–555. doi: 10.1016/0092-8674(90)90658-2. [DOI] [PubMed] [Google Scholar]
  66. Kantarjian H. M., Estey E. H., O'Brien S., Anaissie E., Beran M., Rios M. B., Keating M. J., Gutterman J. Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia. Blood. 1992 Feb 15;79(4):876–881. [PubMed] [Google Scholar]
  67. Kantarjian H. M., Walters R. S., Keating M. J., Smith T. L., O'Brien S., Estey E. H., Huh Y. O., Spinolo J., Dicke K., Barlogie B. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol. 1990 Jun;8(6):994–1004. doi: 10.1200/JCO.1990.8.6.994. [DOI] [PubMed] [Google Scholar]
  68. Kantarjian H. M., Walters R. S., Smith T. L., Keating M. J., Barlogie B., McCredie K. B., Freireich E. J. Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia. Blood. 1988 Nov;72(5):1784–1789. [PubMed] [Google Scholar]
  69. Kitchingman G. R., Rovigatti U., Mauer A. M., Melvin S., Murphy S. B., Stass S. Rearrangement of immunoglobulin heavy chain genes in T cell acute lymphoblastic leukemia. Blood. 1985 Mar;65(3):725–729. [PubMed] [Google Scholar]
  70. Klein G. Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men. Cell. 1983 Feb;32(2):311–315. doi: 10.1016/0092-8674(83)90449-x. [DOI] [PubMed] [Google Scholar]
  71. Kneba M., Bolz I., Linke B., Bertram J., Rothaupt D., Hiddemann W. Characterization of clone-specific rearrangement T-cell receptor gamma-chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencing. Blood. 1994 Jul 15;84(2):574–581. [PubMed] [Google Scholar]
  72. Konopka J. B., Watanabe S. M., Witte O. N. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell. 1984 Jul;37(3):1035–1042. doi: 10.1016/0092-8674(84)90438-0. [DOI] [PubMed] [Google Scholar]
  73. Kreuser E. D., Hetzel W. D., Heit W., Hoelzer D., Kurrle E., Xiros N., Heimpel H. Reproductive and endocrine gonadal functions in adults following multidrug chemotherapy for acute lymphoblastic or undifferentiated leukemia. J Clin Oncol. 1988 Apr;6(4):588–595. doi: 10.1200/JCO.1988.6.4.588. [DOI] [PubMed] [Google Scholar]
  74. Kurzrock R., Gutterman J. U., Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med. 1988 Oct 13;319(15):990–998. doi: 10.1056/NEJM198810133191506. [DOI] [PubMed] [Google Scholar]
  75. Kurzrock R., Shtalrid M., Romero P., Kloetzer W. S., Talpas M., Trujillo J. M., Blick M., Beran M., Gutterman J. U. A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature. 1987 Feb 12;325(6105):631–635. doi: 10.1038/325631a0. [DOI] [PubMed] [Google Scholar]
  76. Lensink D. B., Barton A., Appelbaum F. R., Hammond W. P., 4th Cyclic neutropenia as a premalignant manifestation of acute lymphoblastic leukemia. Am J Hematol. 1986 May;22(1):9–16. doi: 10.1002/ajh.2830220103. [DOI] [PubMed] [Google Scholar]
  77. Linker C. A., Levitt L. J., O'Donnell M., Forman S. J., Ries C. A. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood. 1991 Dec 1;78(11):2814–2822. [PubMed] [Google Scholar]
  78. Linker C. A., Levitt L. J., O'Donnell M., Ries C. A., Link M. P., Forman S. J., Farbstein M. J. Improved results of treatment of adult acute lymphoblastic leukemia. Blood. 1987 Apr;69(4):1242–1248. [PubMed] [Google Scholar]
  79. Lombardi L., Newcomb E. W., Dalla-Favera R. Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell. 1987 Apr 24;49(2):161–170. doi: 10.1016/0092-8674(87)90556-3. [DOI] [PubMed] [Google Scholar]
  80. Maurer J., Janssen J. W., Thiel E., van Denderen J., Ludwig W. D., Aydemir U., Heinze B., Fonatsch C., Harbott J., Reiter A. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet. 1991 May 4;337(8749):1055–1058. doi: 10.1016/0140-6736(91)91706-z. [DOI] [PubMed] [Google Scholar]
  81. McGuire E. A., Hockett R. D., Pollock K. M., Bartholdi M. F., O'Brien S. J., Korsmeyer S. J. The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol Cell Biol. 1989 May;9(5):2124–2132. doi: 10.1128/mcb.9.5.2124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. McMaster M. L., Greer J. P., Greco F. A., Johnson D. H., Wolff S. N., Hainsworth J. D. Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy. J Clin Oncol. 1991 Jun;9(6):941–946. doi: 10.1200/JCO.1991.9.6.941. [DOI] [PubMed] [Google Scholar]
  83. Mellentin J. D., Smith S. D., Cleary M. L. lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell. 1989 Jul 14;58(1):77–83. doi: 10.1016/0092-8674(89)90404-2. [DOI] [PubMed] [Google Scholar]
  84. Miller D. R. Acute lymphoblastic leukemia. Pediatr Clin North Am. 1980 May;27(2):269–291. doi: 10.1016/s0031-3955(16)33851-2. [DOI] [PubMed] [Google Scholar]
  85. Milpied N., Gisselbrecht C., Harousseau J. L., Sebban C., Witz F., Troussard X., Gratecos N., Michallet M., LeBlond V., Auzanneau G. Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy. Cancer. 1990 Aug 15;66(4):627–631. doi: 10.1002/1097-0142(19900815)66:4<627::aid-cncr2820660404>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  86. Mirro J., Kitchingman G., Williams D., Lauzon G. J., Lin C. C., Callihan T., Zipf T. F. Clinical and laboratory characteristics of acute leukemia with the 4;11 translocation. Blood. 1986 Mar;67(3):689–697. [PubMed] [Google Scholar]
  87. Miyamura K., Tanimoto M., Morishima Y., Horibe K., Yamamoto K., Akatsuka M., Kodera Y., Kojima S., Matsuyama K., Hirabayashi N. Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marrow transplantation. Blood. 1992 Mar 1;79(5):1366–1370. [PubMed] [Google Scholar]
  88. Mrsić M., Nemet D., Labar B., Bogdanić V., Radman I., Zupancić-Salek S., Kovacević-Metelko J., Aurer I., Maravić N. Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia. Transplant Proc. 1993 Feb;25(1 Pt 2):1268–1270. [PubMed] [Google Scholar]
  89. Niebrugge D. J., Benjamin D. R. Bone marrow necrosis preceding acute lymphoblastic leukemia in childhood. Cancer. 1983 Dec 1;52(11):2162–2164. doi: 10.1002/1097-0142(19831201)52:11<2162::aid-cncr2820521131>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  90. Nourse J., Mellentin J. D., Galili N., Wilkinson J., Stanbridge E., Smith S. D., Cleary M. L. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell. 1990 Feb 23;60(4):535–545. doi: 10.1016/0092-8674(90)90657-z. [DOI] [PubMed] [Google Scholar]
  91. Ohyashiki K., Ohyashiki J. H., Tauchi T., Fujieda H., Hojo H., Ohtaka M., Saito M., Nakazawa S., Toyama K. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a pilot study which raises important questions. Leukemia. 1991 Jul;5(7):611–614. [PubMed] [Google Scholar]
  92. Omura G. A., Moffitt S., Vogler W. R., Salter M. M. Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis. Blood. 1980 Feb;55(2):199–204. [PubMed] [Google Scholar]
  93. Pees H. W., Radtke H., Schwamborn J., Graf N. The BFM-protocol for HIV-negative Burkitt's lymphomas and L3 ALL in adult patients: a high chance for cure. Ann Hematol. 1992 Nov;65(5):201–205. doi: 10.1007/BF01703945. [DOI] [PubMed] [Google Scholar]
  94. Peterson B. A., Bloomfield C. D. High-dose methotrexate for the remission induction of refractory adult acute lymphocytic leukemia. Med Pediatr Oncol. 1978;5(1):79–84. doi: 10.1002/mpo.2950050112. [DOI] [PubMed] [Google Scholar]
  95. Plunkett W., Liliemark J. O., Estey E., Keating M. J. Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-C. Semin Oncol. 1987 Jun;14(2 Suppl 1):159–166. [PubMed] [Google Scholar]
  96. Pui C. H., Behm F. G., Raimondi S. C., Dodge R. K., George S. L., Rivera G. K., Mirro J., Jr, Kalwinsky D. K., Dahl G. V., Murphy S. B. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med. 1989 Jul 20;321(3):136–142. doi: 10.1056/NEJM198907203210302. [DOI] [PubMed] [Google Scholar]
  97. Radford J. E., Jr, Burns C. P., Jones M. P., Gingrich R. D., Kemp J. D., Edwards R. W., McFadden D. B., Dick F. R., Wen B. C. Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol. J Clin Oncol. 1989 Jan;7(1):58–66. doi: 10.1200/JCO.1989.7.1.58. [DOI] [PubMed] [Google Scholar]
  98. Reynolds T. C., Smith S. D., Sklar J. Analysis of DNA surrounding the breakpoints of chromosomal translocations involving the beta T cell receptor gene in human lymphoblastic neoplasms. Cell. 1987 Jul 3;50(1):107–117. doi: 10.1016/0092-8674(87)90667-2. [DOI] [PubMed] [Google Scholar]
  99. Rizzoli U., Mangoni L., Carella A. M., Aglietta M., Porcellini A., Coleselli P., Angrilli F., Alessandrino E. P., Madon E., Locatelli F. Drug-mediated marrow purging: mafosfamide in adult acute leukemia in remission. The experience of the Italian study group. Bone Marrow Transplant. 1989 Jan;4 (Suppl 1):190–194. [PubMed] [Google Scholar]
  100. Rohatiner A. Z., Bassan R., Battista R., Barnett M. J., Gregory W., Lim J., Amess J., Oza A., Barbui T., Horton M. Intensive chemotherapy for acute lymphoblastic leukaemia in adults. Haematol Blood Transfus. 1990;33:413–418. doi: 10.1007/978-3-642-74643-7_77. [DOI] [PubMed] [Google Scholar]
  101. Rossi J. F., Bataille R., Chappard D., Alexandre C., Janbon C. B cell malignancies presenting with unusual bone involvement and mimicking multiple myeloma. Study of nine cases. Am J Med. 1987 Jul;83(1):10–16. doi: 10.1016/0002-9343(87)90491-8. [DOI] [PubMed] [Google Scholar]
  102. Sarris A. H., Kempin S., Berman E., Michaeli J., Little C., Andreeff M., Gee T., Straus D., Gansbacher B., Filippa D. High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia. Blood. 1992 Mar 1;79(5):1305–1310. [PubMed] [Google Scholar]
  103. Shore S. K., Nabissa P. M., Reddy E. P. Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity. Oncogene. 1993 Nov;8(11):3183–3188. [PubMed] [Google Scholar]
  104. Siena S., Bregni M., Brando B., Ravagnani F., Bonadonna G., Gianni A. M. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood. 1989 Nov 1;74(6):1905–1914. [PubMed] [Google Scholar]
  105. Simonsson B., Burnett A. K., Prentice H. G., Hann I. H., Brenner M. K., Gibson B., Grob J. P., Lönnerholm G., Morrison A., Smedmyr B. Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemia. Leukemia. 1989 Sep;3(9):631–636. [PubMed] [Google Scholar]
  106. Skorski T., Nieborowska-Skorska M., Barletta C., Malaguarnera L., Szcyzlik C., Chen S. T., Lange B., Calabretta B. Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide. J Clin Invest. 1993 Jul;92(1):194–202. doi: 10.1172/JCI116549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Sobol R. E., Mick R., Royston I., Davey F. R., Ellison R. R., Newman R., Cuttner J., Griffin J. D., Collins H., Nelson D. A. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med. 1987 Apr 30;316(18):1111–1117. doi: 10.1056/NEJM198704303161802. [DOI] [PubMed] [Google Scholar]
  108. Soiffer R. J., Roy D. C., Gonin R., Murray C., Anderson K. C., Freedman A. S., Rabinowe S. N., Robertson M. J., Spector N., Pesek K. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse. Bone Marrow Transplant. 1993 Sep;12(3):243–251. [PubMed] [Google Scholar]
  109. Stong R. C., Korsmeyer S. J., Parkin J. L., Arthur D. C., Kersey J. H. Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics. Blood. 1985 Jan;65(1):21–31. [PubMed] [Google Scholar]
  110. Stryckmans P., De Witte T., Bitar N., Marie J. P., Suciu S., Solbu G., Debusscher L., Bury J., Peetermans M., Andrien J. M. Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemia. Semin Oncol. 1987 Jun;14(2 Suppl 1):67–72. [PubMed] [Google Scholar]
  111. Sutton L., Kuentz M., Cordonnier C., Blaise D., Devergie A., Guyotat D., Leblond V., Flesch M., Bordigoni P., Attal M. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities. Bone Marrow Transplant. 1993 Dec;12(6):583–589. [PubMed] [Google Scholar]
  112. Taub R., Kelly K., Battey J., Latt S., Lenoir G. M., Tantravahi U., Tu Z., Leder P. A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) Burkitt lymphoma. Cell. 1984 Jun;37(2):511–520. doi: 10.1016/0092-8674(84)90381-7. [DOI] [PubMed] [Google Scholar]
  113. Taylor P. R., Reid M. M., Bown N., Hamilton P. J., Proctor S. J. Acute lymphoblastic leukemia in patients aged 60 years and over: a population-based study of incidence and outcome. Blood. 1992 Oct 1;80(7):1813–1817. [PubMed] [Google Scholar]
  114. Thiel E., Kranz B. R., Raghavachar A., Bartram C. R., Löffler H., Messerer D., Ganser A., Ludwig W. D., Büchner T., Hoelzer D. Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood. 1989 Apr;73(5):1247–1258. [PubMed] [Google Scholar]
  115. Thirman M. J., Gill H. J., Burnett R. C., Mbangkollo D., McCabe N. R., Kobayashi H., Ziemin-van der Poel S., Kaneko Y., Morgan R., Sandberg A. A. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med. 1993 Sep 23;329(13):909–914. doi: 10.1056/NEJM199309233291302. [DOI] [PubMed] [Google Scholar]
  116. Tucker J., Prior P. F., Green C. R., Ede G. M., Stevenson J. F., Gawler J., Jamal G. A., Charlesworth M., Thakkar C. M., Patel P. Minimal neuropsychological sequelae following prophylactic treatment of the central nervous system in adult leukaemia and lymphoma. Br J Cancer. 1989 Nov;60(5):775–780. doi: 10.1038/bjc.1989.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Urbano-Ispizua A., Matutes E., Villamor N., Ribera J. M., Feliu E., Montserrat E., Grañena A., Vives-Corrons J. L., Rozman C. Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia. Br J Haematol. 1990 Jun;75(2):202–207. doi: 10.1111/j.1365-2141.1990.tb02649.x. [DOI] [PubMed] [Google Scholar]
  118. Vaickus L., Ball E. D., Foon K. A. Immune markers in hematologic malignancies. Crit Rev Oncol Hematol. 1991 Dec;11(4):267–297. doi: 10.1016/1040-8428(91)90029-c. [DOI] [PubMed] [Google Scholar]
  119. Vernant J. P., Marit G., Maraninchi D., Guyotat D., Kuentz M., Cordonnier C., Reiffers J. Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission. J Clin Oncol. 1988 Feb;6(2):227–231. doi: 10.1200/JCO.1988.6.2.227. [DOI] [PubMed] [Google Scholar]
  120. Waldmann T. A. The arrangement of immunoglobulin and T cell receptor genes in human lymphoproliferative disorders. Adv Immunol. 1987;40:247–321. doi: 10.1016/s0065-2776(08)60241-2. [DOI] [PubMed] [Google Scholar]
  121. Westbrook C. A., Hooberman A. L., Spino C., Dodge R. K., Larson R. A., Davey F., Wurster-Hill D. H., Sobol R. E., Schiffer C., Bloomfield C. D. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood. 1992 Dec 15;80(12):2983–2990. [PubMed] [Google Scholar]
  122. Weyman C., Graham-Pole J., Emerson S., August C., Champlin R., Coccia P., Fay J., Harris R., Koch P., Johnson L. Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter survey. Bone Marrow Transplant. 1993 Jan;11(1):43–50. [PubMed] [Google Scholar]
  123. Willemze R., Hillen H., Hartgrink-Groeneveld C. A., Haanen C. Treatment of acute lymphoblastic leukemia in adolescents and a-dults: A retrospective study of 41 patients (1970-1973). Blood. 1975 Dec;46(6):823–834. [PubMed] [Google Scholar]
  124. Williams D. L., Raimondi S., Rivera G., George S., Berard C. W., Murphy S. B. Presence of clonal chromosome abnormalities in virtually all cases of acute lymphoblastic leukemia. N Engl J Med. 1985 Sep 5;313(10):640–641. doi: 10.1056/nejm198509053131016. [DOI] [PubMed] [Google Scholar]
  125. Yap B. S., McCredie K. B., Keating M. J., Bodey G. P., Freireich E. J. Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults. Cancer Treat Rep. 1981;65 (Suppl 1):83–87. [PubMed] [Google Scholar]
  126. Zehnbauer B. A., Pardoll D. M., Burke P. J., Graham M. L., Vogelstein B. Immunoglobulin gene rearrangements in remission bone marrow specimens from patients with acute lymphoblastic leukemia. Blood. 1986 Mar;67(3):835–838. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES